China trims Covid quarantine time by two days

China trims Covid quarantine time by two days


China’s Covid outbreak is at its worst in about half a year. Residents of Hohhot, Inner Mongolia, are pictured here lining up for regular virus testing in their community on Nov. 10, 2022.

Future Publishing | Future Publishing | Getty Images

BEIJING — China reduced the quarantine time for international travelers by two days, state media said Friday.

Instead of having to stay at a centralized quarantine facility for seven days, the new rules stipulate a five day quarantine, followed by three days of home observation, according to state media.

related investing news

Goldman Sachs says buy these stocks ahead of a $2.6 trillion China reopening boom

CNBC Pro
Goldman Sachs says buy these stocks ahead of a $2.6 trillion China reopening boom

The new timeframe also applied to close contacts of Covid infections within China, the report said.

This is a breaking news story. Please check back for updates.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More